Stockreport

Organogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024 [Yahoo! Finance]

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report
PDF Adjusted EBITDA : Fell to $42.6 million for FY 2023, reflecting a decrease of $6.7 million year-over-year. Advanced Wound Care Products : Remained the largest revenue [Read more]